Skip to main content
Year archive

Kuros Biosciences Ltd. — 2021 filings

All 10 regulatory filings released by Kuros Biosciences Ltd. (KURN) in 2021, sourced directly from the official regulator.

10 Filings
2021 Period
2021 filings (10)
Filing Released Lang
Kuros Biosciences reports continued increase in MagnetOs U.S. sales
Earnings Release Q3 2021
2021-10-26 English
Kuros Biosciences to showcase new MagnetOs products at NASS 2021 Annual Meeting
Regulatory Filings
2021-09-28 English
Kuros Biosciences Announces FDA 510(k) Clearance for MagnetOs Easypack PuttyHeadline
Regulatory Filings
2021-09-09 English
Kuros Biosciences Reports Results for First Half 2021
Earnings Release H1 2021
2021-08-11 English
Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuross license agreement with Checkmate Pharmaceuticals
M&A Activity
2021-07-15 English
Kuros Biosciences announces publication of data on MagnetOs in eCM Journal linking MOA to enhanced predictable bone regeneration
Regulatory Filings
2021-06-22 English
Kuros Biosciences to present at upcoming U.S. spine conferences
Regulatory Filings
2021-06-17 English
Kuros Biosciencess commercial roll-out of MagnetOs bone graft exceeds expectations
Earnings Release Q1 2021
2021-06-02 English
Kuros to receive $4 million milestone payment from Checkmate Pharmaceuticals
Regulatory Filings
2021-05-17 English
Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion
Legal Proceedings Report
2021-05-05 English